Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Sep;7(9):592-601.

Managing pain in inflammatory bowel disease

Affiliations

Managing pain in inflammatory bowel disease

Michael J Docherty et al. Gastroenterol Hepatol (N Y). 2011 Sep.

Abstract

Pain is a common complaint in inflammatory bowel disease, and it has significant consequences for patients' quality of life. A thorough evaluation to determine the source of patients' pain should include clinical, laboratory, radiologic, and endoscopic assessments as indicated. Differentiating among active inflammation, secondary complications, and functional pain can be complicated. Even when all active disease is adequately treated, clinicians are often left with the difficulty of managing chronic pain. This paper will review the benefits and limitations of several commonly used treatments and promising future therapies. A suggested treatment algorithm will provide some guidance in this challenging area of inflammatory bowel disease management.

Keywords: Inflammatory bowel disease; irritable bowel syndrome; management; pain.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Mechanisms of pain in inflammatory bowel disease. Nociceptive stimuli can be detected by either somatic primary afferents (red) or visceral primary afferents (blue). ACC

anterior cingulate cortex

Amyg

amygdala

DRG

dorsal root ganglia

PAG

periaqueductal gray matter

RVM

rostroventromedial medulla

SS

somatosensory cortex

Thal

Thalamus

Figure 2
Figure 2
Treatment algorithm for pain in inflammatory bowel disease (IBD). The dashed arrows indicate that the drugs should be used with caution. NSAIDs

nonsteroidal anti-inflammatory drugs

References

    1. Simrén M, Axelsson J, Gillberg R, et al. Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterol. 2002;97:389–396. - PubMed
    1. Schirbel A, Reichert A, Roll S, et al. Impact of pain on health-related quality of life in patients with inflammatory bowel disease. World J Gastroenterol. 2010;16:3168–3177. - PMC - PubMed
    1. Graff LA, Walker JR, Lix L, et al. The relationship of inflammatory bowel disease type and activity to psychological functioning and quality of life. Clin Gastroenterol Hepatol. 2006;4:1491–1501. - PubMed
    1. Sandborn WJ, Feagan BG, Hanauer SB, et al. A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease. Gastroenterology. 2002;122:512–530. - PubMed
    1. De Rooy EC, Toner BB, Maunder RG, et al. Concerns of patients with inflammatory bowel disease: results from a clinical population. Am J Gastroenterol. 2001;96:1816–1821. - PubMed

LinkOut - more resources